Skip to main content

Biodesix Inc

BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001439725

In the last 90 days, Biodesix Inc insiders filed 2 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Biodesix Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of BDSX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders4647+1
Shares4.22M5.12M+904.0K (+21.4%)
Value$85.6M$67.6M−$18.0M (−21.0%)

New holders (7)

Institutions that held Biodesix Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to BDSX in Q2 2021
InstitutionSharesValue% of portfolio
Cannell Peter B & Co Inc205,605$2.72M0.08%
Alyeska Investment Group, L.P.100,000$1.32M0.02%
Nuveen Asset Management, LLC19,512$258.0K0.00%
D. E. Shaw & Co., Inc.15,655$207.0K0.00%
ExodusPoint Capital Management, LP15,100$199.0K0.00%
Trexquant Investment LP11,874$157.0K0.01%
Advisory Services Network, LLC39$1.00K0.00%

Sold out (6)

Institutions that held Biodesix Inc at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of BDSX in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Putnam Investments LLC258,642$5.25M
Millennium Management LLC200,898$4.08M
STRS Ohio700$14.0K
Total Clarity Wealth Management, Inc.207$4.00K
Bank of Montreal87$2.00K
Sowell Financial Services LLC31$0